# Brain Biomarker on Inflammation Response

> **NCT03271814** · PHASE1 · WITHDRAWN · sponsor: **University of Maryland, Baltimore**

## Conditions studied

- Schizophrenia

## Interventions

- **BIOLOGICAL:** LPS
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03271814
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2025-01-01
- **Primary completion:** 2025-12-15
- **Final completion:** 2025-12-15
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI moved to another institution before enrollment could start.
- **Last updated:** 2023-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03271814

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03271814, "Brain Biomarker on Inflammation Response". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03271814. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*